Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.
Weight loss treatments Mounjaro and Zepbound are the primary growth engines for Eli Lilly right now, but the company has ...
Nasdaq3d
Move Over Mounjaro. Eli Lilly Has Another Blockbuster Opportunity in the Making, and No One Is Talking About It.
For the last couple of years, the pharmaceutical sector has become infatuated with glucagon-like peptide 1 (GLP-1) agonists used to treat diabetes and help with chronic weight management.
Got $5,000? 2 Top Healthcare Stocks to Buy in 2025 and Hold Forever.
Eli Lilly started 2024 on a strong note but struggled during the second half of the year. The drugmaker dealt with several ...
2 Healthcare Stocks You Can Buy Right Now Before They Surge Even Higher
Eli Lilly (NYSE: LLY) sells many products across treatment areas, from immunology to neuroscience. The company sells ...
3 Richly Valued Stocks I'll Be Watching Like a Hawk in 2025
Investing in stocks with high valuations isn't necessarily a bad decision, but it's something to be done deliberately and ...
Kyverna Therapeutics Appoints Naji Gehchan, MD, MBA, as Chief Medical and Development Officer
Dr. Gehchan brings decades of successful late-stage clinical development and commercial experience to role, further enhancing Kyverna's senior leadership team to execute ...
As RFK Jr.’s hearings begin, so will scrutiny on his familiarity with key health programs
The job Robert F. Kennedy Jr. is seeking is defined by the task of overseeing Medicare and Medicaid, which he's shown little ...
Investing18h
Duffed chip
US Dollar South African Rand, Coca-Cola Co, Eli Lilly and Company, Apple Inc. Read Vestact 's latest article on Investing.com South Africa.
Contract Pharma6d
Kyverna Therapeutics Appoints Naji Gehchan as Chief Medical & Development Officer
Kyverna Therapeutics Inc., a clinical-stage biopharmaceutical company, has appointed Naji Gehchan, M.D., MBA, as Chief ...